Dublin, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The "Yttrium Trichloride-90 Y (CAS 39271-65-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added ...
China has potentially revolutionized cancer therapy by producing Yttrium-90, a powerful beta-emitting isotope used to target liver tumors, using a commercial heavy-water reactor at the Qinshan Nuclear ...
Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial Results: ...
Therapy-Related Myeloid Leukemias Are Observed in Patients With Chronic Lymphocytic Leukemia After Treatment With Fludarabine and Chlorambucil: Results of an Intergroup Study, Cancer and Leukemia ...
Testing has been completed of a device for carrying out irradiation tests of various radioisotopes - such as yttrium-90 - at the two pressurised heavy water reactors that make up Phase III of the ...
SIR-Spheres® Y-90 resin microspheres are now FDA-approved for unresectable HCC, marking a unique approval for both HCC and mCRC in the U.S. The DOORwaY90 study showed a 98.5% overall response rate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results